Tscan Therapeutics Inc (TCRX)
1.10
+4.76%
Tscan Therapeutics Inc (TCRX) is currently trading at $1.10. This represents a gain of 4.76% from the previous session. With a market capitalization of $0.06B, TCRX is a key component of the Health Care sector. Investors looking to trade TCRX should compare margin rates and options platforms to optimize their portfolio management.
Broker Promotion
Get 15 Free Stocks on Moomoo →
T&Cs Apply. Trade TCRX commission-free.
Trading Platform Comparison
Moomoo
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Good for small traders
IBKR
- Min Deposit: $0
- Commissions: $0–$0.005/share
- Fractional Shares: ✅
- Options: ✅
- Notes: Professional-level tools
Ameritrade
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Strong research tools
Webull
- Min Deposit: $0
- Commissions: $0
- Fractional Shares: ✅
- Options: ✅
- Notes: Easy mobile app
AI Market Sentiment
As of today, Tscan Therapeutics Inc (TCRX) shows a bullish trend. Analysts are watching the 1.13 level closely.
Fundamentals
Mkt Cap0.06B
P/E Ratio0.0000
Volume269,774
60-Day Technical Chart
Advanced Charting
Need more indicators for TCRX? Use the world's #1 platform.
Open TCRX on TradingView →Charting Platforms
TradingView
Advanced charts & indicators, web & mobile
StockCharts
Technical analysis charts with overlays & indicators
BarCharts
Market data, charts, and technical signals
Finviz
Visual stock charts & heatmaps
Yahoo Finance Charts
Basic interactive charts with indicators
Side-by-Side: Stocks Near $1
| Metric |
TCRX +4.76% |
ABTC +3.43% |
AMC +0.43% |
HUMA +4.55% |
|---|---|---|---|---|
| Price | $1.10 | $1.06 | $1.18 | $1.17 |
| Mkt Cap | $0.06B | $0.98B | $0.62B | $0.23B |
| - | View → | View → | View → |
Latest Headlines
Tscan Therapeutics stock plunges after pausing solid tumor trial enrollment
Investing.com • Nov 3, 2025
TScan Therapeutics (NASDAQ: TCRX) extends cash runway to H2 2027; cuts workforce about 30%
Stock Titan • Nov 3, 2025
Great week for TScan Therapeutics, Inc. (NASDAQ:TCRX) institutional investors after losing 73% over the previous year
simplywall.st • Jul 11, 2025
New Analyst Forecast: $TCRX Given $6.0 Price Target | TCRX Stock News
Quiver Quantitative • Nov 4, 2025
2 Overlooked Stocks to Snap Up in 2025
Barchart.com • Oct 16, 2025
● Gemini Agentic AI Analyst Insight for TCRX
Market Education
- Investing $100: Options and Tools for Small Investments - many drops make an Ocean Jul 15, 2023
- Stock Valuation Dec 16, 2023
- I want to day trade, which technical analysis indicators work best. Jul 15, 2023
External Research